Community-Based Complementary and Alternative Medicine: An Integrative Approach to Confronting...
Transcript of Community-Based Complementary and Alternative Medicine: An Integrative Approach to Confronting...
Running head: PREVENTING HEART DISEASE 1
Community-Based Complementary and Alternative Medicine:
An Integrative Approach to Confronting America’s Leading Killers
Myrna Davis Washington
University of the Rockies
Preventing Heart Disease 2
Community-Based Complementary and Alternative Medicine:
An Integrative Approach to Confronting America’s Leading Killers
Taking an integrative approach to health is nothing new.
Since the days of ancient Greek medicine, Plato, and Hippocrates;
physicians have approached healing by balancing the four ‘humors’
(blood, phlegm, black bile, and yellow bile) and modifying
lifestyle behaviors, such as diet and exercise. In recent years,
however, conventional medicine’s original goal of ‘alleviating
suffering’ (based on the Hippocratic Oath taken by every
physician) has been reshaped by a paradigmatic shift in thinking
ushered in by a deeper understanding of anatomy and physiology,
the emergence of new scientific evidence bases (i.e.,
neurobiology, molecular biology, genetics, infectious disease,
etc.), revolutionary medical and technological advances, a
shrinking globe and an increasingly diverse and aging population,
a fledgling economy, and a growing dissatisfaction with the
Preventing Heart Disease 3
costly and curative, aggressively invasive, disease-focused,
treatment-only approach of conventional Western biomedicine.
Medicine’s ‘new’ model, an Integrative Medicine (IM),
refines traditional Western medicine’s original goal with a
holistic, preventative, person-centered, healing-oriented
approach committed to solving health problems with an
understanding of the profound implications of biopsychosocial-
spiritual interconnectedness in the healing process and the use
of evidence-based, non-invasive, natural and therapeutic
interventions (i.e., botanical medicine, lifestyle modification,
therapeutic touch, diet, exercise, community-based organizations,
etc.) whenever possible (Kligler & Lee, 2004). This paper
explores the impact that IM can have on attenuating medicine’s
revised goal by examining the impact of community-based
organizations (CBOs) and complementary and alternative medicine
(CAM) strategies on alleviating the suffering caused by two of
the leading causes of morbidity and mortality in the United
States today: heart disease and stroke; discussed herein as
Cardiovascular Disease (CVD).
What Are The Leading ‘Killers’ in the United States?
Preventing Heart Disease 4
In 2010, the U.S. National Vital Statistics System (NVSS, as
cited in CDC, 2013) recorded nearly 2.5 million deaths in the
United States and listed the ten leading causes of morbidity and
mortality as: 1) heart disease, 2) cancer, 3) chronic lower
respiratory diseases, 4) stroke, 5) unintentional injuries, 6)
Alzheimer’s disease, 7) diabetes, 8) nephritis/ nephrotic
syndrome/ nephrosis, 9) influenza and pneumonia, and 10) suicide.
As the number one and number four ‘killers’ in the United States,
heart disease and stroke are combined as one chronic disease:
Cardiovascular Disease (CVD).
Cardiovascular Disease: What Is It and What IS Its Impact?
As stated above, CVD is made up of heart disease (myocardial
infarction, cardiac failure, coronary artery disease, heart
attack, angina, and arrhythmias) and stroke (a ‘brain attack’
occurring when a clot blocks the blood supply to the brain or
when a blood vessel in the brain bursts). In describing the
‘suffering’ caused by CVD, evidence indicates that heart disease
can lead to heart attacks/myocardial infarctions (MI),
arrhythmia, atherosclerosis, and death; and that stroke can cause
death (immediate in approximately 6% of cases), paralysis,
Preventing Heart Disease 5
significant disability, speech and motor disabilities, emotional
problems (CDC, 2013; Oberg et al., 2009). However, the overall
effects of CVD are indicated by multilevel and catastrophic
‘suffering’. According to the 2010 NVSS findings, CVD accounts
for one in three deaths (nearly 800 thousand), costs Americans an
estimated $444 billion in direct and indirect health care costs,
accounts for one of every six American dollars spent on health
care, and promises to have an even more devastating economic
impact on the nation’s healthcare system as the U.S. population
continues to diversify and age (CDC, 2013).
Other, more telling, CVD statistics include the following:
1) More than one out of three (83 million) U.S. adults currently
lives with one or more types of CVD; 2) An estimated 935,000
heart attacks and 795,000 strokes occur each year; 3) Nearly 68
million adults have high blood pressure, and about half do not
have this condition under control; 4) An estimated 71 million
adults have high cholesterol (i.e., high levels of low-density
lipoprotein cholesterol); and 5) Nearly 2 of 3 do not have this
condition under control (CDC, 2013). Despite these statistics,
CVD deaths have continued to decline over the past 40 years, due
Preventing Heart Disease 6
in large part to risk factor reductions (e.g., reducing high
blood pressure and high cholesterol) and modifying lifestyle and
health behaviors (i.e., smoking cessation, regular moderate
activity, and adopting balanced, healthful eating habits) (CDC,
2013).
Who is Most at Risk of Experiencing CVD?
While anyone who fails to adopt preventative lifestyle
modifications can put themselves at risk of contracting CVD, data
from the 2009 Behavioral Risk Factor Surveillance System (BRFSS,
as cited in CDC, 2013) suggests that at-risk individuals can most
readily be identified by correlating individual heart health with
seven heart health risk factors (high blood pressure, high
cholesterol, smoking, overweight, diabetes, lack of physical
activity, and less than 5 servings of fruit and vegetable a day),
with ideal heart health being associated with having ideal values
for each heart-health risk measure and poor heart health having
ideal values for two or less of the seven factors. According to
findings from this survey, of the nearly 10% of Americans
reporting poor cardiovascular health: 1) those 65 years or older
have the lowest heart health and the highest percentage of poor
Preventing Heart Disease 7
heart health; 2) adults aged 18 to 34 years have the lowest
percentage of poor health; 3) those aged 35 to 54 years have the
highest percentage of ideal heart health; 4) women had better
heart health than men across all categories; 5) Non-Hispanic
whites and Asian/Pacific Islanders had consistently better heart
health than Hispanics; 6) Non-Hispanic African Americans and
American Indian/Alaska Natives had poorer heart health than their
counterparts in the other three groups; 7) and adults who had
received college or postgraduate degrees had consistently higher
levels of ideal heart health (CDC, 2013).
How Are The Social Determinants of Health Associated with CVD?
In addition to the above findings, results from the 2009
BRFSS suggested that the pressing issue of dealing with health
disparities across racial, cultural, and ethnic lines was
compounded by the social determinants of health (the social
circumstances in which people are born, grow up, live, work, and
age, as well as the systems put in place to deal with illness)
and a wider set of forces, including economics, social policies
and politics, population differences in environmental exposures,
health care access, utilization or quality, health status, health
Preventing Heart Disease 8
outcomes, and access to digital technology (the “digital divide”)
(Gibbons, 2005; CDC, 2013). Research supports this with evidence
of consistent lower health care quality and poorer CDV outcomes
in ethnic minorities or patients in the lower socioeconomic
status (SES) (Oberg, Fitzpatrick, Lafferty, and LoGerfo, 2009).
According to one study (Oberg et al., 2009), while health
care disparities along racial lines has been documented in all
aspects of care, and the rate of CDV-related deaths has
differentiated little at one year (39.7% for blacks and 37.6% for
whites; P = .001), evidence shows that minorities are
disproportionately represented in lower SES strata and that,
compared with lower-SES patients, more affluent and better-
educated patients are more likely to receive cardiac
rehabilitation (43.9% vs 25.6%, P < .001) or to be seen by a
cardiologist (56.7% vs 47.8%, P < .001) (Oberg et al., 2009).
These studies also show that while some health disparities may be
attributable to underlying differences in access to care (e.g.,
privately insured vs Medicare or Medicaid; associated stigma),
the ratio of minorities enrolled in Medicaid is substantially
higher than in the general population (Oberg et al., 2009). What
Preventing Heart Disease 9
this suggests and reinforces is the idea that the solution to
disparities in health care may be solved, for the most part, by
making health care more affordable, and, therefore, more
accessible to everyone; an economic problem most likely best
addressed at the community or local level.
How Should CVD Be Addressed?
Despite being one of the most widespread and costly health
problems facing the country today, CVD has been shown to be one
of the most preventable chronic diseases. Yet, research
demonstrates that despite the significant progress in
understanding its pathophysiology and declining rates of
occurrence and frequency, CVD continues to be the major cause of
mortality and morbidity in the US and the world today (CDC, 2013;
Weiner & Rabbani, 2010). Based on this information, the answer to
how CVD should be addressed appears logically simple: a
preventable disease, such as CVD, should be addressed by using a
preventative intervention. A rapidly expanding body of research
concurs by demonstrating high efficacy in CVD prevention with the
use of integrative, preventative, absolute-risk-based therapies
that deviate from the traditional “treatment only” approach of
Preventing Heart Disease 10
conventional Western medicine by emphasizing self-care, lifestyle
modifications, and, in some cases, taking medication (CDC, 2013).
To put the above findings into action, the U.S. Department
of Health and Human Services’ Healthy People 2020 (the third set of
ten-year health objectives released to assist federal, state, and
local governments in promoting health, preventing disease, and
improving the health of every U.S. citizens) has devised a
blueprint for improving cardiovascular health and quality of life
through prevention, detection, and treatment of risk factors for
heart attack and stroke; and the American Heart Association (AHA)
has defined its 2020 cardiovascular health goal as a 20%
improvement in the cardiovascular health of all Americans and a
20% reduction in deaths from CVD (CDC, 2013; MedicineZine, 2011).
Can Community-Based Organizations Be Utilized for CVD Risk
Reduction?
Firstly, what is a community and what are community-based
organizations (CBOs)? According to MacQueen et al. (2001), a
community is “a group of people with diverse characteristics who
are linked by social ties, share common perspectives, and engage
in joint action in geographical locations or settings” (para. 3).
Preventing Heart Disease 11
Working from this definition, a community can be a church, a
school, an organization, the workplace, the Internet, or a public
organization; and can be based on culture, ethnicity, gender,
sexual preference, interests, skills, occupation, beliefs, or
values. According to the American Academy of Pediatrics (AAP,
2005), a CBO is a locally controlled and consumer-oriented agency
that fosters self-reliance and self-sufficiency in the overall
advancement of human welfare and reflects the values of the
community in which it resides (AAP, 2005).
What Are the Strengths and Weaknesses of Using a CBO to Address
CVD?
According to the AAP (2005), CBOs have expert knowledge in
community needs, community credibility, resources, the culture of
the clients they serve, funding streams, and unique advocacy
opportunities. In addition, each CBO has a mission to serve a
defined group of individuals with a set of programs or services
to meet some of the needs of the community (AAP, 2005). Moreover,
most CBOs, by their nature, are flexible and resourceful in
assisting individuals in crisis and have the infrastructure to
partner with other community organizations and tap into community
Preventing Heart Disease 12
opinion, despite having a narrow or broad focus of the human
services they provide (AAP, 2005).
An increasing number of studies show community-based risk
reduction strategies to be highly efficacious in preventing the
incidence of CVD (Cobiac, Magnus, Barendregt, Carter, & Vos,
2012; Weiner & Rabbani, 2012). One study (Weiner & Rabbani, 2010)
examined the value of adhering to evidence-based secondary
prevention therapies (i.e., exercise, smoking cessation,
controlling diabetes, diet and weight reduction, cardiac
rehabilitation, influenza vaccination, environmental issues, and
depression screening) for CVD prevention. As these are evidence-
based, non-pharmacological, non-invasive, preventative,
integrative strategies that can be implemented at the state,
local, and community levels, CBOs and complementary and
alternative medicine (CAM) strategies appear to be ‘tailor-made’
for monitoring and educating people on how to modify their
lifestyles and behaviors to reduce the risk of future
confrontations with heart disease and possible heart attacks
(Weiner & Rabbani, 2012).
What is Complementary and Alternative Medicine (CAM)?
Preventing Heart Disease 13
The National Center for Complementary and Alternative
Medicine (NCCAM, as cited in Georgetown University Law Library’s
“Complementary & Alternative Medicine Research Guide”, 2013)
defines Complementary and Alternative Medicine (CAM) as “a group
of diverse medical and health care systems, practices, and
products that are not presently considered to be part of
conventional medicine.” NCCAM also divides CAMs into four major
areas: 1) natural products (herbs/ botanicals, vitamins and
minerals, and probiotics; widely marketed, readily available to
consumers, and often sold as dietary supplements); 2)
manipulative and body-based practices (i.e., Acupuncture,
healing/therapeutic touch, Reiki, massage therapy, spinal
manipulation, etc.); 3) mind-body medicine (i.e., mindfulness or
transcendental meditation, guided imagery, and relaxation
techniques such as breathing exercises, guided imagery, and
progressive muscle relaxation); and 4) movement therapies,
traditional healers, energy medicine and whole medical systems
(i.e., a broad range of Eastern and Western movement-based
approaches, including yoga, Feldenkrais method, Alexander
Preventing Heart Disease 14
technique, Pilates, Rolfing Structural Integration, and Trager
psychophysical integration) (NCCAM, 2013).
According to NCCAM (2013), the ten most common CAM
approaches in 2007 were natural products (17%), deep breathing
(12.7%), meditation (9.4%), chiropractic and osteopathic (8.6%),
massage (8.3%), yoga (6.1%), diet-based therapies (3.6%),
progressive relaxation (2.9%), guided imagery (2.2%) and
homeopathic treatment (1.8%). Other CAM approaches presented by
NCCAM (2013) include the practices of traditional healers,
Ayurvedic medicine, traditional Chinese medicine, homeopathy, and
naturopathy. Although definitive evidence on the efficacy of
using CAM approaches to address CVD is lacking, evidence of
increasing interest and utilization of CAM approaches can be seen
in the fact that 40% of Americans now use some form of CAM
therapy to address their health problems, due primarily to rising
and costly health care costs.
Despite Their Effectiveness, Are CBOs and CAMs Cost-effective?
As stated above, as recent research indicates that 40% of
the U.S. population already use CAM therapies, based to a large
degree on the costliness of pharmaceuticals and technological
Preventing Heart Disease 15
procedures; the answer to this question would appear to be ‘yes’.
However, in light of a 2012 study conducted by Cobiac et al.,
that answer might be premature. Cobiac et al. (2012) examined the
cost-effectiveness of changing cardiovascular disease prevention
from pharmaceutical treatment for everyone with hypertension or
elevated cholesterol, to absolute risk-based prevention. After
evaluating the cost-effectiveness of statins, diuretics, ACE
inhibitors, calcium channel blockers and beta-blockers, for
Australian men and women (35 to 84 years) who had never
experienced a heart disease or stroke event; the authors found
that despite demonstrating cost-effectiveness that could free up
health dollars for more important health issues, changing to
pure, absolute risk-based prevention intervention will neither
lead to substantial changes in the number of patients eligible
for treatment nor produce substantial net differences in
population health effects between conventional and integrative
approaches (Cobiac et al., 2012). Although this clearly
necessitates the need for an integrative approach and for more
studies in the future, what this most readily obviates is a case
Preventing Heart Disease 16
for using community-based CAM approaches and lifestyle management
approaches for CVD prevention.
What Is the Role of CAM Approaches in Addressing CVD?
Sullivan (2001) researched the role of CAM approaches (i.e.,
nutrition, herbs, mind-body-spirit, acupuncture/oriental
medicine, lifestyle changes, nutritional supplements/vitamins,
and massage) and lifestyle management in managing patients with
coronary artery disease. Findings based on preliminary studies in
the areas of CAM indicated that because CAM focuses on patient-
centered lifestyle choices, comprehensive lifestyle interventions
(i.e., diet, exercise, relaxation, and stress management) may
benefit patients with cardiac disease (Sullivan, 2001). At the
very least, says Sullivan (2001), the surge in interest in CAM
modalities warrants further investigation and will promote
research, education, and clinical application of CAM strategies
in U.S. medical school curricula; and provide a novel venue for
the promotion of CAM as appropriate rehabilitation strategies in
CVD patients.
Is There a Place for Alternative Medicine in Addressing CVD?
Preventing Heart Disease 17
As he predicted, Sullivan’s research did spark an interest in
using CAM approaches in CVD prevention and rehabilitation.
However, prevention and rehabilitation are not the only areas
where community-based organizations and CAMs have shown efficacy.
In fact, although CAM approaches have demonstrated high efficacy
in reducing the occurrence of CDV, the most significant impact
can be seen in preventing recurrent CVD occurrences with the use
of aggressive risk factor reduction strategies, including a
combination of pharmacologic and lifestyle recommendations
(Oberg, Fitzpatrick, Lafferty, and LoGerfo, 2009). In a study of
372 myocardial infarction (MI) patients (50 of whom died and 144
of whom were rehospitalized), Oberg et al.’s findings indicated
that using combined pharmacologic and lifestyle recommendations
demonstrated a 20% improvement in one-year survival rates, from
74.7% with no care to 95.7% with optimal care (2009). Therefore,
the answer to the question of whether there is a place for
alternative medicine in addressing CVD is: Complementary (or
adjunctive),Yes; Alternative: No; and neither should be used
unless supported by valid scientific research. With this in mind,
Preventing Heart Disease 18
the following section presents a case for the use of community-
based CAM approaches for CVD prevention and rehabilitation.
How Can Community-based CAM Approaches Be Used to Address CVD?
According to Oberg et al. (2009), a number of organizations
(i.e., the American Heart Association [AHA], American College of
Cardiology [ACC], and European Society of Cardiology) have
published guidelines that specify the evidence-based components
of optimal secondary prevention of CVD. This is based in part,
posit Oberg et al. (2009), on evidence suggesting that because
discharge planning and outpatient secondary prevention have not
demonstrated improvement as rapidly as processes of optimal
inpatient care, guidelines associated with nonpharmacologic
interventions (cardiac rehabilitation, smoking cessation,
physical activity, weight reduction) should be considered (Oberg
et al., 2009). One example is the AHA’s Get with the Guidelines,
a community-based quality improvement program. Recent results
from facilities implementing Get With the Guidelines demonstrate
that, compared with drug recommendations that are made 86% to 93%
of the time, nonpharmacologic interventions are recommended only
26% to 54% of the time and that, in addition to secondary
Preventing Heart Disease 19
prevention of CVD, lifestyle modifications reduce the risk for
many other chronic diseases and have been prioritized as a common
agenda by the CDC, the AHA, the American Diabetes Association,
and American Cancer Society (Oberg et al., 2009).
Another community-based CAM intervention that has
demonstrated efficacy is the AHA’s “My Heart My Life” (MHML; AHA,
2013). Although racial disparities have been reported in access
to computers and the Internet, MHML has shown effectiveness in
addressing CVD as an interactive web-based intervention with the
goal of educating and informing anyone on the Internet or in the
global community on a heart-healthy lifestyle. The seven sub-
sections (accessible from the drop-down menu) include: 1) a
nutrition center (healthy diet, shopping, cooking, recipes,
dining out, cookbooks, and health guides); 2) physical activity
(Start Walking, National Walking Day); 3) healthier kids
(programs, tips on making healthy homes, activities for kids, and
teaching gardens); 4) weight management (BMI, losing weight, and
obesity); 5) stress management (stress-fighting habits, proactive
stress techniques, four ways to deal with stress); 6) fats & oils
(fats 101, meet the fats, the dish with Dr. Eckel, Restaurant
Preventing Heart Disease 20
Resources); and 7) quitting smoking (resources and tips for
quitting smoking). These mirror the previously-cited BRFSS risk
factors and align with community-based, preventative, risk-based
CAM strategies outlined by BRFSS and referenced above (Cobiac
et al., 2012; Oberg et al., 2009; Sullivan, 2001; Weiner &
Rabbani, 2012). And, while racial disparities in computer
accessibility may retard or impede deliverance of this strategy
to ethnic minorities or those in the lower SES bracket, this
writer does not believe the disparity to be disproportionate (at
least, not with respect to ethnicity).
One final exploration of community-based CAM intervention is
the CDC’s “Reducing Out-of-Pocket Costs (ROPC)” program for
patients with high blood pressure and high cholesterol, two of
the most evidenced risk antecedents for CVD (CDC, 2013). ROPC is
based on a systemic review of five studies reviewing its economic
impact and fourteen studies demonstrating a reduction of out-of-
pocket medical costs for patient costs to be positively
associated with improvements in adherence to blood pressure (a
decrease in systolic and diastolic blood pressure) and
cholesterol-lowering medications (increased by a median of 3.2
Preventing Heart Disease 21
percentage points: 2.0 to 4.6) and blood pressure (decreased by a
median of 8.7mmHg; 1.9 to 10.9) and cholesterol outcomes (a
decrease in total cholesterol, low-density lipoprotein, and
triglycerides) (CDC, 2013). Results from these two groups of
studies are applicable to adults (aged 18 to 64), women and men,
low income patients, Hispanic, white, and African-American
patients (CDC, 2013); rendering this program an effective CAM
strategy for addressing CVD prevention and health disparities.
In a nutshell, ROPC involves program and policy changes that
reduce or cover the costs of CVD preventive services such as
medications, behavioral counseling (e.g., nutrition counseling),
and behavioral support (e.g., community-based weight management
programs, gym membership) by providing new or expanded treatment
coverage and lowering or eliminating patient out-of-pocket
expenses (i.e., copayments, coinsurances, deductibles) (CDC,
2013). Additionally, ROPC is coordinated through the community’s
health care system and preventive services are delivered in
clinical and non-clinical settings; can be implemented alone or
in conjunction with other interventions to enhance patient-
provider interaction (i.e., team-based care, medication
Preventing Heart Disease 22
counseling, and patient education); and communicates program and
policy changes using targeted health messages (i.e., supporting
materials, publications, promotional materials, etc.) to increase
awareness and use of covered services (CDC, 2013).
Is Integrative Medicine More Effective In Treating CVD than
Conventional Medicine?
As stated previously, despite the ‘best efforts of
conventional medicine’ and a more profound understanding of the
disease pathophysiology of CVD, CVD continues to affect one in
three Americans. While the strengths and weakness of conventional
medicine were addressed in the introduction as the logic behind
the current paradigmatic shift in medicine and in thinking, in
general, it is clear from a preponderance of the evidence
presented in this paper, that CVD is most appropriately addressed
by using risk-based, preventative, community-based CAM approaches
because they are evidence-based, non-invasive, ‘natural’,
holistic, patient-centered, empowering, healing-centered, based
on patient-centered lifestyle choices, and, in most cases, cost-
effective and, therefore, accessible. If “the CVD numbers”
presented in this paper indicate anything, they demonstrate that
Preventing Heart Disease 23
if conventional medicine continues to do what it has done in the
past, it will garner the same results. They also admonish that
if a change in outcome is desired, then a change in interventions
must be affected (the definition of insanity). That change must
necessarily come in the form of community-based CAM approaches
that prevent, rehabilitate, and restore; three of the fundamental
principles underlying the foundations of Integrative Medicine.
In conclusion, as an integrative approach was actually
identified in the original Hippocratic Oath (e.g., respect for
hard-won scientific gains, use any measures requires to treat,
warmth, sympathy, and understanding; respect for patient privacy;
patient-centeredness, and the use of disease prevention whenever
possible) taken by every U.S. physician, preventative, risk-
based, community-based CAM approaches, used in conjunction with
cholesterol-lowering and blood pressure-reducing medicine (an
integrative approach), appear to be tailor-made for addressing
CVD as one of the nation’s most urgent and pressing health
problems. This way, no one is left out. While the evidence does
not definitively support their efficacy in addressing the number
one and the number four causes of death in the U.S., it does
Preventing Heart Disease 24
promote interest in CAM approaches and, therefore, provides
opportunities for new research to refine and deepen our
understanding of the world around and within us by validating or
refuting accepted anecdotal evidence of what worked in the very
distant and not-so-distant past. As Jung asserted, healing and
therapy should consist of “whatever works.” As diversity aligns
itself along individual, rather than racial, ethnic, community,
or national lines; it is important for health and health
approaches to ‘fit’ the individual needs of every person; a feat
requiring little more than preparation, tenacity, an open and
inquisitive mind, a willingness to view things from multiple
perspectives, and the opportunity to pull it all together. In
the words of Henry Hartman: “Success happens when preparation
meets opportunity.” The question is, are we ready?
Preventing Heart Disease 25
References
American Academy of Pediatrics (AAP). (2005). Community-based
Resident Projects Toolkit: A guide to partnering with
communities to improve child health. Retrieved from
http://www.devaap.org/commpeds/CPTI/Toolkit-Bod-
2005.pdf#page=30
American Heart Association (AHA). (2013). My heart my life.
Retrieved from
http://www.heart.org/HEARTORG/GettingHealthy/GettingHealthy_
UCM_001078_SubHomePage.jsp
Centers for Disease Control and Prevention (CDC). (2012). Health,
United States, 2012 In Brief edition. Retrieved from
http://www.cdc.gov/nchs/data/hus/hus12_InBrief.pdf
Centers for Disease Control and Prevention (CDC). (2013). Chronic
disease prevention and health promotion: Heart disease and
stroke prevention. Retrieved from
Preventing Heart Disease 26
http://www.cdc.gov/chronicdisease/resources/publications/AAG
/dhdsp.htm
Cobiac, L. J., Magnus, A., Barendregt, J. J., Carter, R., & Vos,
T. (2012). Improving the cost-effectiveness of
cardiovascular disease prevention in Australia: A modeling
study. BMC Public Health, 12, 398.
doi:http://dx.doi.org/10.1186/1471-2458-12-398
Georgetown University Law Library. (2013). Complementary & Alternative
Medicine Research Guide. Retrieved from
http://www.law.georgetown.edu/library/research/guides/camedi
cine.cfm#other-useful-resources
Medecinezine. (2011). Healthy People 2020. Retrieved
from http://medicinezine.com/information/healthy-people-
2020/
Oberg, E.B., Fitzpatrick, A.L., Lafferty, W.E, & LoGerfo, J.P..
(2009). Secondary prevention of myocardial infarction with
nonpharmacologic strategies in a Medicaid cohort. Preventing
Chronic Disease, 6(2), A52. Retrieved from
http://www.cdc.gov/pcd/issues/2009/
apr/08_0083.htm
Preventing Heart Disease 27
Pearson, T., Blair, S., Daniels, S., Eckel, R., Fair, J.,
Fortmann, S., et al. (2002). AHA Guidelines for primary
prevention of cardiovascular disease and stroke: 2002.
Update: Consensus panel guide to comprehensive risk
reduction for adult patients without coronary or other
atherosclerotic vascular diseases. Retrieved from
http://circ.ahajournals.org/content/106/3/388.full.pdf
Sullivan, M. J. (2001). Integrative medicine and nutrition in CAD
coronary artery disease. Clinical and Investigative Medicine, 24(3), 0.
Retrieved from http://search.proquest.com/docview/196429106?
accountid=39364
Weiner, S. D., & Rabbani, L. E. (2010). Secondary prevention
strategies for coronary heart disease. Journal of Thrombosis and
Thrombolysis, 29(1), 8-24.
doi:http://dx.doi.org/10.1007/s11239-009-0381-8